ArticleJCO oncology advances2026

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

Yu-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.